Selective functions of angiopoietins and vascular endothelial growth factor on blood vessels: The concept of "vascular domain"

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 67, Issue , 2002, Pages 171-180

  Sato, T N ^a   Loughna, S ^a   Davis, E C ^a   Visconti, R P ^a   Richardson, C D ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN; ANGIOPOIETIN 1; CD31 ANTIGEN; PROTEIN TYROSINE KINASE; VASCULOTROPIN; ANGIOPOIETIN RECEPTOR;

ANGIOGENESIS; ARTERY; BLOOD VESSEL; CAPILLARY; CONFERENCE PAPER; CONTROLLED STUDY; ELECTRON MICROSCOPY; EMBRYO; EMBRYO DEVELOPMENT; HANDEDNESS; HEART DEVELOPMENT; HUMAN; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SMOOTH MUSCLE FIBER; VENOUS CIRCULATION; ARTICLE; BLOOD VESSEL WALL;

EID: 0038124418     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.2002.67.171     Document Type: Conference Paper

References (24)

1. Davis S., Aldrich T.H., Jones P.F., Acheson A., Bruno J., Radjiewski C., Compton D., Maisonpierre P.C., and Yancopoulos G.D. 1996. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87: 1161.
2. Edwards W.D. 1998. Applied anatomy of the heart. In Mayo Clinic practice of cardiology (ed. E.R. Giuliani et al.), p. 422. Mosby, St. Louis, Missouri.
3. Ferrara N., Heinsohn H., Walter C.E., Buting S., and Thomas G.R. 1995. The regulation of blood vessel growth by vascular endothelial growth factor. Ann. N.Y. Acad. Sci. 752: 246.
4. Folkman J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1: 27.
5. Hungerford J.E., Hoeffler J.P., Bowers C.W., Dahm L.M., Falchetto R., Shabanowtz J., Hunt D.F., and Little C.D. 1997. Identification of a novel marker for primordial smooth muscle and its differential expression pattern in contractile vs noncontractile cells. J. Cell Biol. 137: 925.
6. Isner J.M. 2002. Myocardial gene therapy. Nature 415: 234.
7. Langman J. 1990. Langman's medical embryology, 6th edition (ed. T.W. Sadler). Williams and Wilkins, Baltimore, Maryland.
8. Lawson N.D., Scheer N., Pham V.N., Kim C.H., Chitnis A.B., Campos-Ortega J.A., and Weinstein B.M. 2001. Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development 128: 3675.
9. Liu Y., Wada R., Yamashita T., Mi Y., Deng C.X., Hobson J.P., Rosenfeldt H.M., Nava V.E., Chae S.S., Lee M.J., Liu C.H., Hla T., Spiegel S., and Proia R.L. 2000. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J Clin. Invest. 106: 951.
10. Loughna S. and Sato T.N. 2001. A combinatorial role of angiopoietin-1 and orphan receptor TIE1 pathways in establishing vascular polarity during angiogenesis. Mol. Cell 7: 233.
11. Maisonpierre P.C., Suri C., Jones P.F., Bartunkova S., Wiegand S.J., Radziejewski C., Compton D., McClain J., Aldrich T.H., Papadapoulos N., Daly T.J., Davis S., Sato T.N., and Yancopoulos G.D. 1997. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277: 55.
12. Partanen J., Armstrong E., Makela T.P., Korhonen J., Sandberg M., Renkonen R., Knuutila S., Huebner K., and Alitalo K. 1992. A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol. Cell. Biol. 12: 1698.
13. Patterson M. 2001. Two-step regulation of asymmetry. Nat. Rev. Genet. 2: 157.
14. Sato T.N. 2000. A new role of lipid receptors in vascular and cardiac morphogenesis. J. Clin. Invest. 106: 939.
15. Sato T.N., Qin Y., Kozak C.A., and Audus K.L. 1993. tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. Proc. Natl. Acad. Sci. 90: 9355.
16. Suri C., Jones P.F., Patan S., Bartunkova S., Maisonpierre P.C., Davis S., Sato T.N., and Yancopoulos G.D. 1996. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87: 1171.
17. Suri C., McClain J., Thurston G., McDonald D.M., Zhou H., Oldmixon E.H., Sato T.N., and Yancopoulos G.D. 1998. Increased vascularization in mice overexpressing angiopoietin-1. Science 282: 468.
18. Thurston G., Suri C., Smith K., McClain J., Sato T.N., Yancopoulos G.D., and McDonald D.M. 1999. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286: 2511.
19. Valenzuela D.M., Griffiths J.A., Rojas J., Aldrich T.H., Jones P.F., Zhou H., McClain J., Copeland N.G., Gilbert D.J., Jenkins N.A., Huang T., Papadopoulos N., Maisonpierre P.C., Davis S., and Yancopoulos G.D. 1999. Angiopoietins 3 and 4: Diverging gene counterparts in mice and humans. Proc. Natl. Acad. Sci. 96: 1904.
20. Visconti R.P., Richardson C.D., and Sato T.N. 2002. Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF). Proc. Natl. Acad. Sci. 99: 8219.
21. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., and Holash J. 2000. Vascular-specific growth factors and blood vessel formation. Nature 407: 242.
22. Yost H.J. 1999. Diverse initiation in a conserved left-right pathway? Curr. Opin. Genet. Dev. 9: 422.
23. -. 2001. Establishment of left-right asymmetry. Int. Rev. Cytol. 203: 357.
24. Zhong T.P., Childs S., Leu J.P., and Fishman M.C. 2001. Gridlock signalling pathway fashions the first embryonic artery. Nature 414: 216.